Progentos Therapeutics is developing regenerative medicines for chronic diseases, focusing on a new approach to treating multiple sclerosis that stimulates the body's natural repair mechanisms.
investor of
Metrics
marketPRIVATE
msh_idCOM:PROGENTOS
websitehttps://www.progentos.com
source_ref4b365320-2024-45f9-a366-597d924aff0e
products_or_servicesRegenerative medicines for chronic diseases, specifically a new approach to treating multiple sclerosis